Recent News

Day: October 21, 2024

Press Release 

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024 by pmn.admin

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

No comment
Continue Reading
Press Release 

KnowBe4 Sheds Light on the Alarming Trends of Human Trafficking Through Social Engineering in the UAE

October 21, 2024 by pmn.admin

DUBAI, UAE, Oct. 21, 2024 (GLOBE NEWSWIRE) — Human trafficking continues to be an issue in the UAE, particularly affecting foreign workers from Africa and South and Southeast Asia. Lured with false promises of high-paying jobs, victims arrive in the UAE only to have their passports confiscated and find themselves in forced labor or even […]

No comment
Continue Reading
Press Release 

DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

October 21, 2024 by pmn.admin

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased DexCom securities during […]

No comment
Continue Reading